For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
GEFDPKLRFAQSPVARLATSTPDGTPHLVPVVFALGARRPAEATGADVIYTAVDAKRKTTQRLRRLANLE HNPRASVLVDSYADDWTQLWWVRADGVAAIHRDGEVMRAAYRLLRAKYAQYQSVPLNGPVIAIAVQRWAS WHA*
Operon Prediction Model: Genebank
Paralogs
species | id | gene | e-value | identity (len) | annotation |
M. tuberculosis H37Rv | Rv0121c | - | - | 100% (144) | hypothetical protein Rv0121c |
Closest Orthologs (e-value cutoff: 1e-4)
species | id | gene | e-value | identity (len) | annotation |
M. bovis AF2122 / 97 | Mb0126c | - | 2e-81 | 100.00% (144) | hypothetical protein Mb0126c |
M. gilvum PYR-GCK | Mflv_1079 | - | 1e-44 | 59.57% (141) | pyridoxamine 5'-phosphate oxidase-related, FMN-binding |
M. leprae Br4923 | - | - | - | - | - |
M. abscessus ATCC 19977 | - | - | - | - | - |
M. marinum M | MMAR_0322 | - | 6e-51 | 66.67% (141) | hypothetical protein MMAR_0322 |
M. avium 104 | MAV_5188 | - | 2e-52 | 67.13% (143) | pyridoxamine 5'-phosphate oxidase family protein |
M. smegmatis MC2 155 | MSMEG_6526 | - | 2e-43 | 58.33% (144) | pyridoxamine 5'-phosphate oxidase family protein |
M. thermoresistible (build 8) | TH_2134 | - | 2e-47 | 60.99% (141) | CONSERVED HYPOTHETICAL PROTEIN |
M. ulcerans Agy99 | MUL_4800 | - | 2e-51 | 66.90% (145) | hypothetical protein MUL_4800 |
M. vanbaalenii PYR-1 | Mvan_5743 | - | 1e-46 | 60.14% (143) | pyridoxamine 5'-phosphate oxidase-related, FMN-binding |
CLUSTAL 2.0.9 multiple sequence alignment Mflv_1079|M.gilvum_PYR-GCK ------MTDPGA----------------FDAPGVFAEAPVAMLATAGTDA Mvan_5743|M.vanbaalenii_PYR-1 MAQRLPPRDPAVNESDRSCEPYPGVMADFDHEAAFAAAPVAMLATAGLDA TH_2134|M.thermoresistible__bu MAPGNPSGVPSSGPDPHG----------FDPEAMFAAAPVAALATVGSDG Rv0121c|M.tuberculosis_H37Rv ------------------------MG-EFDPKLRFAQSPVARLATSTPDG Mb0126c|M.bovis_AF2122/97 ------------------------MG-EFDPKLRFAQSPVARLATSTPDG MMAR_0322|M.marinum_M ---------------------------MFDPAVRFTQSPVARLATVTPEG MUL_4800|M.ulcerans_Agy99 ------------------------MGEVFDPAVRFTQSPVARLATVTPEG MAV_5188|M.avium_104 ------------------------MG-EFDARARFGRASVARLATVSPGG MSMEG_6526|M.smegmatis_MC2_155 -------------------------MAEFDAVTAFADAPAAVLSTLNADG ** * :..* *:* . Mflv_1079|M.gilvum_PYR-GCK VPHLVPVVFALPVGRS-------DVLYTAVDAKPKSTQRLRRLRNIEENP Mvan_5743|M.vanbaalenii_PYR-1 VPHLVPVVFAVPSHRS-------DILYTAVDAKPKTTQRLRRLTNIENNP TH_2134|M.thermoresistible__bu QPHLVPVVFAVHGG----------AVYTAVDAKPKTTQRLRRLVNIEANP Rv0121c|M.tuberculosis_H37Rv TPHLVPVVFALGARRPAEATGA-DVIYTAVDAKRKTTQRLRRLANLEHNP Mb0126c|M.bovis_AF2122/97 TPHLVPVVFALGARRPAEATGA-DVIYTAVDAKRKTTQRLRRLANLEHNP MMAR_0322|M.marinum_M IPHVVPVVFAVDN----------DLIFTAVDAKPKSTRRLRRLTNIERTP MUL_4800|M.ulcerans_Agy99 IPHVVPVVFAVDN----------DLIFTAVDAKPKSTRRLRRLTNIERTP MAV_5188|M.avium_104 QPHLVPVVFALAQGPDADHDADPDVVYTAVDAKPKTTRRLRRLANIDANP MSMEG_6526|M.smegmatis_MC2_155 APHLVPVVFAVHVPHVE---GQPARIYTAVDAKRKTTRNLRRLANIDRDS **:******: ::****** *:*:.**** *:: . Mflv_1079|M.gilvum_PYR-GCK SVSLLVDHYDDDWSKLWWVRADGVASIHHSGVEMATGYALLRGKYPQYQR Mvan_5743|M.vanbaalenii_PYR-1 AVSLLVDHYEDDWTRLWWVRADGKAAIHHSGVEMATGYTLLRAKYPQYQR TH_2134|M.thermoresistible__bu RVSLLVDHYTEDWTQLWWVRADGIATIHRSGEQMATGYALLRRKYPQYQR Rv0121c|M.tuberculosis_H37Rv RASVLVDSYADDWTQLWWVRADGVAAIHRDGEVMRAAYRLLRAKYAQYQS Mb0126c|M.bovis_AF2122/97 RASVLVDSYADDWTQLWWVRADGVAAIHRDGEVMRAAYRLLRAKYAQYQS MMAR_0322|M.marinum_M QVSLLVDHYDDDWTQLWWVRADGVAQIHPAGAVLHTGYRLLRAKYAQYQS MUL_4800|M.ulcerans_Agy99 QVSLLVDHYDDDWTQLWWVRADGVAQIHPAGAVLHTGYRLLRAKYAQYQS MAV_5188|M.avium_104 QVSLLADHYADDWTRLWWVRADGLATIHRDGPALDTGYRLLRAKYPQYQS MSMEG_6526|M.smegmatis_MC2_155 RVSLLVDHYSDDWTQLWWVRADGVATTHHSGDEVATGYALLRAKYHQYER .*:*.* * :**::******** * * * : :.* *** ** **: Mflv_1079|M.gilvum_PYR-GCK VELDGPVVTVEIRRWSSWTGS Mvan_5743|M.vanbaalenii_PYR-1 VELNGPVITVEIDHWSSWHGG TH_2134|M.thermoresistible__bu ITLDGPVVAVEIRHWSSWHA- Rv0121c|M.tuberculosis_H37Rv VPLNGPVIAIAVQRWASWHA- Mb0126c|M.bovis_AF2122/97 VPLNGPVIAIAVQRWASWHA- MMAR_0322|M.marinum_M VLLDGPVICVAVRRWSSWHA- MUL_4800|M.ulcerans_Agy99 VLLDGPVICVAVRRWSSWHA- MAV_5188|M.avium_104 VPLDGPVIAIAVRRWSGWAP- MSMEG_6526|M.smegmatis_MC2_155 VSLDGPVISVEVSRWASWQA- : *:***: : : :*:.*